NALOXONE HYDROCHLORIDE
| Brand name | NALOXONE HYDROCHLORIDE |
|---|---|
| Active ingredient | NALOXONE HYDROCHLORIDE |
| Strength | 4MG/SPRAY |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Modality | Small molecule |
| FDA approval | April 2024 |
| Marketing status | OTC |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.